Previous 10 |
home / stock / glpgf / glpgf news
Source: Barron's Gilead ( GILD ) reports Q2 earnings July 30th. Analysts expect revenue of $5.51 billion and EPS of $1.72. The revenue estimate implies 4% growth sequentially. Investors should focus on the following key items: HCV Could Show Signs Of Life Gilead has experienced a ste...
Introduction From Spain last week to Scandinavia today. Whereas we discussed Fluidra’s ( OTC:FLUIF ) dominant position in the pool and wellness sector last week, in this week’s edition of Focus on Europe we are heading north to check up on Norsk Hydro ( OTCQX:NHYDY )...
News, Short Squeeze, Breakout and More Instantly...
Galapagos Genomics Ord Company Name:
GLPGF Stock Symbol:
OTCMKTS Market:
Galapagos Genomics Ord Website:
Mechelen, Belgium; June 14, 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present encouraging new data from the ongoing Phase 1/2 ATALANTA-1 study of CD19 CAR-T candidate, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma (R/R NHL) at the annual Euro...
Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next generation MAGE-A4 TCR T-cell therapy) produced on Galapagos’ decentralized manufacturing platform in patients with head & neck cancer Uza-cel has shown enc...
BCA's national network of blood centers will provide decentralized manufacturing services for Galapagos' CAR-T product candidates, close to cancer treatment centers Collaboration enables rapid deployment of Galapagos' decentralized CAR-T platform across the U.S., improving patient access ...